相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency
G. Khan et al.
ANNALS OF ONCOLOGY (2010)
Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function
Reza Khosravan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pharmacokinetics of sunitinib in hemodialysis
H. Izzedine et al.
ANNALS OF ONCOLOGY (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Tolerance of Sunitinib in Dialyzed Patients With Metastatic Renal Cell Carcinoma
Michael M. Vickers et al.
CLINICAL GENITOURINARY CANCER (2009)
Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
Antonius A. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Treatment of Metastatic Renal Cell Cancer With Sunitinib During Chronic Hemodialysis
Stefan Zastrow et al.
UROLOGY (2009)
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States
Claudio Jeldres et al.
UROLOGY (2009)
Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma
Laurent Zini et al.
UROLOGY (2009)
Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma
Laurent Zini et al.
BJU INTERNATIONAL (2008)
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
CANCER (2008)
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
Toni K. Choueiri et al.
CANCER (2007)
Medical progress - Assessing kidney function - Measured and estimated glomerular filtration rate
Lesley A. Stevens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
RC Flanigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
GHJ Mickisch et al.
LANCET (2001)
分享论文
